SEPTEMBER 25, 2018 • 3:00 pm ET
Molecular diagnostics is increasingly being utilized to help guide targeted therapy in solid organ tumors. Cytopathologists are at the forefront of triaging specimens during rapid on-site evaluation and selecting specimens for ancillary testing. Therefore, it is imperative that practicing cytopathologists stay abreast of up-to-date diagnostic and prognostic ancillary tests utilizing limited cytologic material. This presentation will focus on cytologic substrates for ancillary studies, along with the advantages and disadvantages of each, to help the participants triage and devise optimal strategies for ancillary testing in their own practices.